Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Rokoko Smartglove

Research Leaders

6 sponsors active, led by University of Florence

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Unknown2
Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT07422636Completed

Wet and Dry Biomarkers to Predict Secondary Injury in Stroke: From Bench to Bedside - The NIMBLE Study

NCT06683326Not ApplicableNot Yet RecruitingPrimary

Smart-gloves Hand Motion Tracking for Live Endoscopic Submucosal Dissection Training

NCT05824624Not ApplicableUnknownPrimary

The Effect Of Animal-Assisted Intervention

NCT05725694Unknown

Acute Ischaemic STROKE: From LAboratory to the Patient's BED

Showing all 4 trials

Research Network

Common Treatments

  • Rokoko Smartglove1
  • Routine Care1
  • Animalassisted Intervention1

Active Sponsors

  • University of Florence2
  • Careggi Hospital2
  • Istituto di Neuroscienze Consiglio Nazionale delle Ricerche2
  • Tokat Gaziosmanpasa University1
  • Carol Davila University of Medicine and Pharmacy1

Top Investigators

Related Conditions

  • Acute Ischemic Stroke2
  • Cerebral Edema2
  • Hemorrhagic Transformation Due To Acute Stroke2
  • Reperfusion Injury2
  • Fear1

Activity Timeline